Protein kinase A (PKA) plays multiple roles in neurons. The localization and specificity of PKA are largely controlled by A-kinase anchoring proteins (AKAPs). However, the dynamics of PKA in neurons and the roles of specific AKAPs are poorly understood. We imaged the distribution of type II PKA in hippocampal and cortical layer 2/3 pyramidal neurons in vitro and in vivo. PKA was concentrated in dendritic shafts compared to the soma, axons, and dendritic spines. This spatial distribution was imposed by the microtubule-binding protein MAP2, indicating that MAP2 is the dominant AKAP in neurons. Following cAMP elevation, catalytic subunits dissociated from the MAP2-tethered regulatory subunits and rapidly became enriched in nearby spines. The spatial gradient of type II PKA between dendritic shafts and spines was critical for the regulation of synaptic strength and long-term potentiation. Therefore, the localization and activity-dependent translocation of type II PKA are important determinants of PKA function.
INTRODUCTION
Signaling events mediated by protein kinase A (PKA) are critical for many neuronal functions. PKA is important for learning and memory in Aplysia, flies, and mice (Abel et al., 1997; Byrne and Kandel, 1996; Dubnau et al., 2003) . Consistently, PKA is involved in multiple forms of synaptic plasticity (Blitzer et al., 1998; Brandon et al., 1997; Chevaleyre et al., 2007; Frey et al., 1993; Greenberg et al., 1987; Lu et al., 2007; Tzounopoulos et al., 1998; Weisskopf et al., 1994; Yasuda et al., 2003) , including hippocampal long-term potentiation (LTP). PKA has also been implicated in protein trafficking, protein degradation, gene transcription, the regulation of neuronal excitability and other neuronal functions (Choi et al., 2002; Ehlers, 2000; Goldsmith and Abrams, 1992; Greenberg et al., 1987; Hoshi et al., 2005; Impey and Goodman, 2001; Inan et al., 2006; Pedarzani and Storm, 1993) .
Protein kinase A (PKA) is a tetrameric protein consisting of two identical regulatory subunits and two catalytic subunits (Francis and Corbin, 1994; Scott, 1991) . Each regulatory subunit binds and inhibits a catalytic subunit at the resting state. Binding of cAMP to the regulatory subunit releases and activates the catalytic subunit ( Figure 1A ). PKA isoforms are classified into types I and II based on the regulatory subunits (Francis and Corbin, 1994) , with type II, especially IIb, thought to be the dominant isoform in many neurons (Brandon et al., 1997; Brandon et al., 1998; Ventra et al., 1996) .
PKA exerts its function via a wide range of substrates spanning multiple neuronal compartments. For example, at dendritic spines, PKA can phosphorylate AMPA and NMDA glutamate receptors and inhibitor-1, which is an endogenous inhibitor of protein phosphotase-1, to modulate synaptic plasticity (Blitzer et al., 1998; Esteban et al., 2003; Lee et al., 2000; Raman et al., 1996) . PKA phosphorylation of AMPA receptors also regulates the sorting of these receptors into recycling or degradation pathways (Ehlers, 2000) . In dendrites, PKA phosphorylates stargazin to regulate the trafficking of AMPA receptors (Chetkovich et al., 2002; Choi et al., 2002) . PKA also phosphorylates dendritic potassium channels to regulate neuronal excitability (Hoffman and Johnston, 1998; Lin et al., 2008; Pedarzani and Storm, 1993) . In addition, PKA plays important roles in transcriptional control (Montminy, 1997; Shaywitz and Greenberg, 1999) and the regulation of the presynaptic terminal (Leenders and Sheng, 2005; Turner et al., 1999; Tzounopoulos et al., 1998; Weisskopf et al., 1994) .
Specificity in PKA signaling is believed to arise at least in part from compartmentalization of PKA (Buxton and Brunton, 1983; Rich et al., 2001; Zaccolo and Pozzan, 2002) . The subcellular localization of PKA, especially type II PKA, is controlled by A kinase anchoring proteins (AKAPs; Figure 1A ; Wong and Scott, 2004) . AKAPs bind to the N-terminal dimerization domain of PKA regulatory subunits and typically contain a second domain that binds to the cytoskeleton or intracellular scaffolds, thus targeting PKA to specific subcellular locations (Wong and Scott, 2004) . More than 50 AKAPs have been identified, many of which are expressed in neurons (Bauman et al., 2004; Tasken and Aandahl, 2004) . However, the spatial distribution of PKA in neurons, and how this distribution is shaped by specific AKAPs, is largely unknown. When activated, the catalytic subunit of PKA is released from the regulatory subunit. The spatial range of freed catalytic subunits in neuronal compartments has not been characterized.
We have used two-photon and confocal fluorescence microscopy to measure the distribution of PKA subunits in hippocampal and layer 2/3 pyramidal neurons in dissociated cultures, brain slices and in vivo. Type II PKA isoforms were enriched in dendritic shafts compared to dendritic spines. This dendritic targeting was mediated by the microtubule-binding protein MAP2. Catalytic subunits activated by cAMP elevations dissociated from regulatory subunits and rapidly translocated from dendritic shafts to become enriched in spines, presumably to phosphorylate targets in the spine. The spatial regulation of type II PKA is an important determinant of PKA function in neurons.
RESULTS

Type II PKA Is Enriched in Dendrites
To measure the localization of type II PKA in neurons, we tagged the regulatory subunit IIb (RIIb) of PKA with monomeric enhanced green fluorescent protein (mEGFP; Zacharias et al., 2002) at the C terminus. The cDNAs of RIIb-mEGFP and a red volume marker (mCherry or DsRed Express; Shaner et al., 2004) were introduced into cultured hippocampal slices using biolistic gene transfer. Using two-photon laser scanning microscopy, we quantified the relative concentration of RIIb-mEGFP throughout individual CA1 neurons as the ratio of green fluorescence over red fluorescence (G/R) (Figure 1 ).
RIIb-mEGFP was excluded from the nucleus when compared with the red cytosolic marker ( Figure 1B4 ) and enriched in dendrites compared to the soma ( Figure 1B3 ). The concentration of RIIb increased with distance from the soma and reached a steady level in apical and basal dendrites (G/R = 227% ± 32% at 57.5 mm, normalized to 12.5 mm from the center of soma, n = 6, p < 0.01; Figure 1C , red). A soluble fluorescent protein, monomeric Venus (mVenus), was distributed uniformly throughout the cell (G/R = 97% ± 3%, n = 5, p > 0.1; Figure 1C , black). Higher magnification images in the soma revealed that RIIb was associated with filamentous structures, likely the microtubule cytoskeleton ( Figure 1B5 , seen in 6/7 cells). RIIb was excluded from the axon and presynaptic boutons compared to dendrites (G/R = 28% ± 8%, 50 mm from axon initial (B) Representative two-photon images of a CA1 neuron in a cultured hippocampal slice that was cotransfected with RIIb-mEGFP and DsRed Express. All but (B4) are maximum value projections. White box in (B3) corresponds to the blow-ups in (B5) and (B6). Arrowheads: (B5), a cytoskeletal structure; in (B6), axon; (B7), presynaptic bouton. Triangles in (B6) point to thin dendrites without saturated pixels. Pixel sizes: (B1-B4), 0.31 mm; (B5-B7), 0.08 mm.
(C) Green/red ratios along the radius away from the center of the soma (see Experimental Procedures for definition). For the CAT/RIIb combination (orange), CAT was tagged with mEGFP and RIIb was untagged. All data were normalized to the value at 12.5 mm from the center of the soma before averaging. n = 5 for mVenus, RIb, and CAT/RIIb; n = 6 for RIa, RIIa and RIIb. Error bars are SEM. (D) Green/red ratios along proximal axons, in distal axons, and in boutons. Values are normalized to the G/R of thin basal dendrites. (E) Representative image of CA1 neuron expressing RIIa-mEGFP and DsRed Express. (F) Representative image of CA1 neurons expressing CAT-mEGFP, RIIb and DsRed Express. Scales of (E) and (F) are the same as (B1) and (B5).
segment, 21% ± 5% at distal axon and 16% ± 3% at presynaptic boutons, n = 5, for all values p < 0.01; Figures 1B6, 1B7 , and 1D, red). The other type II regulatory subunit, RIIa, was also enriched in dendrites (G/R = 212% ± 22%, n = 6, p < 0.01) and excluded from axons (G/R = 27% ± 3% at 50 mm, n = 6, p < 0.001; Figures  1C, 1D , and 1E). In contrast, type I regulatory subunits RIa and RIb were not enriched in dendrites (G/R RIa = 104% ± 7%, n = 6, p > 0.1; and G/R RIb = 102% ± 5%, n = 5, p > 0.1) and only modestly excluded from axons (G/R RIa = 62% ± 4%, n = 9, p < 0.01; and G/R RIb = 74% ± 6%, n = 7, p < 0.01 at 50 mm; Figures 1C and 1D , and see Figure S1 available online). When a mEGFP-tagged catalytic subunit (CAT-mEGFP) was coexpressed with untagged RIIb ( Figures 1C, 1D , and 1F), the catalytic subunit was also enriched in dendrites compared to soma (G/R = 154% ± 12%, n = 5, p < 0.02) and excluded from the axon (G/R = 41% ± 6% at 50 mm, n = 6, p < 0.001), consistent with the supposition that catalytic subunits bind to regulatory subunits at resting conditions (Francis and Corbin, 1994; Scott, 1991) . We conclude that type II PKA is enriched in the dendrite and excluded from the axon in CA1 pyramidal neurons.
Type II PKA Is Excluded from Spines at the Resting State
We next analyzed the subcellular distribution of PKA in dendrites and dendritic spines ( Figure 2 ). PKA is thought to reside in spines because PKA has many important postsynaptic functions and several AKAPs are concentrated in the postsynaptic density (Bauman et al., 2004; Gomez et al., 2002; Husi et al., 2000) . However, type II PKA subunits were enriched in dendritic shafts compared to neighboring spines (Figures 2A, 2C , and 2D), although PKA was still detectable in many spines ( Figure S2 ). We computed a spine enrichment index SEI = log 2 ([Green/Red] spine / [Green/Red] dendrite ) ( Figure 2D ). A positive SEI implies enrichment in the spine, whereas a negative value indicates exclusion from the spine. As a control, the soluble protein mVenus had a SEI close to zero (0.043 ± 0.004, n = 42; Figures 2C6 and 2D ). Both RIIa and RIIb had negative SEI values (SEI RIIa = À1.29 ± 0.07, n = 59, p < 0.001; and SEI RIIb = À1.28 ± 0.06, n = 83, p < 0.001; Figures 2C  and 2D ), indicating that they were excluded from spines. In contrast, RIa and RIb distributed evenly between dendrite and spine (SEI RIa = À0.097 ± 0.04, n = 74, p = 0.015; and SEI RIb = À0.11 ± 0.05, n = 72, p = 0.025; a = 0.0017 after Bonferroni correction for the six tests). When co-expressed with RIIb, CAT-mEGFP was also excluded from spines (SEI = À0.84 ± 0.05, n = 63, p < 0.001; Figures 2A, 2C3 , and 2D). A similar subcellular distribution of type II PKA was observed in CA3 neurons ( Figure S3 ). However, CAT-mEGFP was not excluded from spines under these conditions when expressed alone, possibly because overexpressed catalytic subunits saturated endogenous regulatory subunits (data not shown). Finally, SEIs and spine volumes were not correlated ( Figure S4 ). We next tested if type II PKA was also excluded from dendritic spines in living mice. CAT-mEGFP, RIIb, and DsRed Express were introduced into layer 2/3 pyramidal neurons in the somatosensory cortex using in utero electroporation (Gray et al., 2006; Saito and Nakatsuji, 2001; Tabata and Nakajima, 2001 ). CATmEGFP was excluded from spines in acute brain slices prepared from 2-to 3-week-old mice (SEI = À0.693 ± 0.04, n = 31, p < 0.001; Figures 2B and 2D) . Consistently, CAT-mEGFP was also excluded from spines in living adolescent mice (SEI = À0.57 ± 0.05, n = 69, p < 0.001; Figures 2B and 2D) . We conclude that type II PKA is enriched in dendritic shafts compared to spines in pyramidal neurons.
Endogenous PKA Is Excluded from Spines Overexpression of PKA or tagging PKA with fluorescent proteins could perturb the spatial distribution of PKA in neurons. We therefore measured directly the distribution of endogenous PKA using immunocytochemistry. Dissociated cultures of rat hippocampal neurons were transfected with the cytosolic marker EGFP and stained using an antibody against the PKA catalytic subunits (PKA-NT, US Biologicals; Figures 2D and  2E1 ). The specificity of the antibody was verified by western blots and by immunostainings using the antibody pre-incubated with the antigen peptide ( Figure S5 , see also Figure S9A ). Endogenous PKA catalytic subunits were enriched in the dendritic shaft compared to neighboring spines (SEI = À1.8 ± 0.16, n = 35, p < 0.001). Similar results were obtained using a second antibody against the PKA catalytic subunits ( Figure S5C ). Furthermore, endogenous PKA RIIb was also enriched in dendritic shafts compared to spines (SEI = À1.30 ± 0.12, n = 36, p < 0.001; Figures 2D, 2E2, and S5). In addition, CAT-mEGFP was enriched in dendritic shafts in layer 2/3 pyramidal neurons in brain slices even without co-expression of RIIb (SEI = À0.598 ± 0.06, n = 41, p < 0.001; Figures 2B3 and 2D ). This indicates that endogenous regulatory subunits were also excluded from spines and were probably in excess of endogenous catalytic subunits. Finally, overexpression and tagging with fluorescence proteins are more likely to disrupt, rather than create, the PKA gradient we observed. Indeed, computer simulations indicate that increasing RIIb concentration by overexpression is likely to have minimal effects on SEI values ( Figure S6 ). When RIIb concentrations approach AKAP concentrations, the PKA gradient collapses. These results show that in the resting state endogenous PKA is enriched in dendritic shafts compared to dendritic spines.
Dendritic Targeting of PKA Is Mediated by MAP2
To identify the mechanisms of type II PKA localization, we carried out a deletion analysis of the regulatory subunit. The N-terminal 47 residues of RIIb, which contain the dimerization domain and the AKAP-binding domain, were sufficient for the spine exclusion (SEI = À2.04 ± 0.08, n = 42, p < 0.001; Figure 3A) . A previous study showed that deleting the first five residues (S2-I6) of RIIa disrupted its binding to AKAPs without affecting dimerization and other functions (Hausken et al., 1994) . Deleting these residues in RIIa and the corresponding sequences in RIIb results in mutants (RIIa-D2-6 and RIIb-D2-5, respectively) that expressed at a level similar to that of the wild-type subunits in neurons ( Figure S7 ). However, the PKA gradient from dendritic shafts to spines was disrupted (SEI RIIa-D2-6 = À0.19 ± 0.04, n = 76, p < 0.001 c.f. RIIa; and SEI RIIb-D2-5 = 0.15 ± 0.05, n = 60, p < 0.001 c.f. RIIb; Figure 3A ). Thus, a dendritically-localized AKAP is responsible for concentrating type II PKA in dendritic shafts.
The distribution of type II PKA resembled that of the abundant microtubule-binding protein MAP2 (Dehmelt and Halpain, 2005) , which was the first AKAP identified (Theurkauf and Vallee, 1982) .
Indeed, linking the microtubule binding domain (MTBD) of MAP2 to RIIb-D2-5, which by itself does not bind AKAPs and distributes evenly between the dendritic shaft and spines, restored the spine exclusion (SEI = À1.86 ± 0.1, n = 40, p < 0.001 c.f. RIIb-D2-5; Figure 3A ). To test if MAP2 is necessary for dendritic localization of PKA, we analyzed the subcellular distribution of RIIb-mEGFP in CA1 neurons in cultured hippocampal slices prepared from mice in which the PKA binding site of MAP2 was genetically deleted (MAP2D1-158; Khuchua et al., 2003) .
The localization of RIIb-mEGFP was partially disrupted in heterozygous neurons (SEI wt = À1.61 ± 0.07; and SEI heterozygous = À0.97 ± 0.07, n = 84; p < 0.001; Figures 3B and 3C ). In homozygous neurons RIIb-mEGFP even became slightly enriched in spines (SEI = 0.50 ± 0.04, n = 83, p < 0.001), possibly by binding to other AKAPs in spines that are dominated by MAP2 in wildtype neurons ( Figures 3B and 3C ). Under our experimental conditions spines occupy $6% of the dendritic volume (see Experimental Procedures). An SEI value of À1.61 in wild-type neurons implies that nearly 98% of total RIIb is restricted to dendritic shafts by MAP2. We conclude that, whereas other AKAPs are present in neurons, MAP2 is the dominant AKAP in pyramidal neurons that anchors type II PKA to dendritic shafts.
Activated PKA Catalytic Subunit Translocates to Become Enriched in Spines
We next asked whether the distribution of PKA changes upon activation by cAMP. Neurons in hippocampal slices expressing CAT-mEGFP, RIIb and mCherry were stimulated by bath application of 50 mM forskolin, an adenylyl cyclase activator, and 100 mM IBMX, a phosphodiesterase inhibitor, which cause intracellular cAMP elevations. CAT-mEGFP moved rapidly into spines upon stimulation where it remained as long as forskolin and IBMX were present (SEI before = À0.84 ± 0.05; and SEI after = 0.442 ± 0.03; n = 63, p < 0.001; Figures 4A, 4B, and 4D). Activated CAT-mEGFP even became enriched in spines as indicated by the positive SEI value (p < 0.001). The distribution of RIIbmEGFP did not change upon activation (SEI before = À1.66 ± 0.07; and SEI after = À1.81 ± 0.07; n = 33, p = 0.14) ( Figure 4C ). The catalytic subunit showed similar dynamics in cortical layer 2/3 neurons in acute brain slices from mice electroporated with CAT-mEGFP and DsRed Express, both with and without RIIb ( Figure 4E ). Furthermore, endogenous cAMP activators, such as the neuromodulators norepinephrine (NE; Raman et al., 1996) and dopamine (Otmakhova and Lisman, 1998) , were sufficient to trigger translocation of the catalytic subunit into spines (SEI before = À1.04 ± 0.09; and SEI after = À0.35 ± 0.10; n = 41, p < 0.001; Figure 4F and data not shown), although these effects were weaker compared to forskolin and IBMX stimulation. These data suggest that catalytic subunits dissociate from type II regulatory subunits in the presence of cAMP. Although the regulatory subunits are still anchored in dendrites, freed catalytic subunits translocate, probably by diffusion, into spines. These freed catalytic subunits become enriched in spines, presumably by binding to abundant PKA targets in spines. Bloodgood and Sabatini, 2005; Gray et al., 2006) . CAT-mPAGFP was more mobile in dendritic shafts after the application of forskolin/IBMX compared to resting conditions (t before = 12.3 ± 1.9 s; and t after = 6.1 ± 1.5 s; n = 15, p < 0.001, sign test; Figure 5 ). The diffusional relaxation of photoactivated CATmPAGFP was complex, even in elevated cAMP ( Figure 5B and data not shown). The decay curves suggest the presence of slowly and rapidly diffusing populations of molecules, perhaps reflecting an incomplete release of the catalytic subunits from the regulatory subunits. In contrast to the diffusion in dendritic shafts, the effective diffusion in spines was similar before and after cAMP elevation (t before = 4.6 ± 0.6 s; and t after = 4.5 ± 0.4 s; n = 17, p = 1). These measurements show that cAMP elevations increase the diffusional mobility of PKA catalytic subunits in dendritic shafts.
PKA Localization Shapes Synaptic Strength
PKA phosphorylation of AMPA receptors facilitates their insertion into synapses (Esteban et al., 2003; Lee et al., 2000; Man et al., 2007; Oh et al., 2006; Sun et al., 2005; Swayze et al., 2004) . We therefore asked whether the spatial gradient of PKA between the dendritic shaft and spines is important for regulating the postsynaptic sensitivity to glutamate. We expressed wild-type RIIbmEGFP in layer 2/3 cortical neurons and measured the AMPA receptor-mediated glutamate sensitivity at individual spines in acute brain slices (P14-P21) using two-photon glutamate uncaging (Carter and Sabatini, 2004; Matsuzaki et al., 2001; Sobczyk et al., 2005) . We tuned the parameters so that the resulting uncaging-evoked excitatory postsynaptic currents (uEPSC, À11.6 ± 1.2 pA) mimic the size of miniature EPSCs in layer 2/3 pyramidal neurons (15-20 pA; Myme et al., 2003) . To minimize variability, we also performed control measurements from untransfected cells in the same set of brain slices under matched conditions. The volumes of the stimulated spines were similar between transfected neurons and untransfected controls in the same slices (normalized volumes V RIIb = 96% ± 5%, n = 100; versus V same-slice control = 100% ± 5%, n = 82; p = 0.53). However, transfected neurons had significantly smaller uEPSC than untransfected neurons (uEPSC RIIb = 67% ± 4%; versus uEPSC same-slice control = 100% ± 10%; p < 0.002; Figure 6 ). The RIIb mutant (RIIb-D2-5), which cannot bind AKAPs and distributes evenly between dendritic shaft and spines, did not show this dominant-negative effect (uEPSC RIIb-D2-5 = 93% ± 6%, n = 97; versus uEPSC same-slice control = 100% ± 7%, n = 85; p = 0.43; and V RIIb-D2-5 = 105% ± 6%; versus V same-slice control = 100% ± 6%; p = 0.57). However, tethering the microtubule-binding domain of MAP2 to the mutant RIIb (RIIb-D2-5-MTBD) rescued the dominant-negative effect (uEPSC RIIb-D2-5-MTBD = 72% ± 5%, n = 85; versus uEPSC same-slice control = 100% ± 11%, n = 75; p < 0.02; and V RIIb-D2-5-MTBD = 92% ± 4%; versus V same-slice control = 100% ± 5%; p = 0.25). Computer simulations suggest that overexpression of wild-type RIIb, but not AKAP-binding deficient mutant RIIb, can lead to a large reduction in PKA activity in spines induced by transient cAMP ( Figure S8 ). These results imply that overexpression of RIIb reduces PKA activity in spines, leading to decreased AMPA receptor-mediated glutamate sensitivity. Taken together, the MAP2-mediated PKA localization is important in setting the strength of excitatory synapses.
PKA Localization Modulates LTP Induction
The strength of excitatory synapses is regulated by activity-dependent synaptic plasticity, such as long-term potentiation (LTP). Activation of the PKA-activating b-adrenergic receptors by norepinephrine (NE) enhances the magnitude of LTP induced by relatively weak synaptic stimuli (Gelinas and Nguyen, 2005; Gelinas et al., 2008; Hu et al., 2007; Thomas et al., 1996; Winder et al., 1999) . We therefore asked whether the MAP2-mediated anchoring of type II PKA to dendritic shafts regulates LTP induction. We first examined whether standard LTP induced with tetanic stimulation (2 3 100 Hz 3 1 s, 30 s interval) is impaired in CA1 of MAP2D1-158 mice, in which the binding between PKA and MAP2 but not with other AKAPs is disrupted. LTP in brain slices from homozygous mice (À/À) was not significantly different from heterozygous or wild-type littermates (potentiation P wt = 59% ± 6%, n = 10; P heterozygous = 54% ± 7%, n = 7; and P homozygous = 49% ± 9%, n = 10, homozygous; Figure 7) .
We next examined if the binding between MAP2 and PKA is required for the facilitation of LTP in response to weaker stimuli (900 pulses at 10 Hz). Norepinephrine enhanced the potentiation in wild-type mice (P NE = 47% ± 6%, n = 8; and P control = 20% ± 4%, n = 6; p < 0.01). However, this enhancement was absent in heterozygous (P NE = 21% ± 5%, n = 8; p < 0.01 c.f. wild-type; and P control = 12% ± 6%, n = 9) and homozygous mice (P NE = 19% ± 8%, n = 11; p < 0.02 c.f. wild-type; and P control = 15% ± 6%, n = 11; Figure 7 ). This is consistent with the observation that localization of type II PKA is disturbed even in heterozygous neurons ( Figure 3C ). The expression levels of the PKA catalytic subunit and RIIb were not reduced in the hippocampus of the mutant mice ( Figure S9 ). Our results therefore suggest that mislocalization of type II PKA might lead to defective phosphorylation of PKA substrates and misregulation of LTP thresholds. Indeed, we found that epinephrine-induced GluR1 phosphorylation was abnormal in MAP2D1-158 mice ( Figure S10 ). We conclude that the MAP2 anchoring of type II PKA to dendritic shafts is critical for norepinephrine facilitation of LTP induction. Since MAP2D1-158 mice have deficits in contextual fear conditioning, our results suggest that modulation of LTP by the stress hormone norepinephrine might be an important synaptic mechanism underlying learned fear.
DISCUSSION
We measured the subcellular distribution of PKA in hippocampal and cortical layer 2/3 pyramidal neurons in vitro and in vivo. Type II PKA was enriched in dendrites compared to dendritic spines less than one micrometer away. Type II PKA was also excluded from axons and presynaptic terminals. The localization of type II PKA catalytic subunits was regulated by cAMP such that activated catalytic subunits translocated from dendritic shafts to become enriched in spines. This spatial regulation of PKA was important for controlling the glutamate sensitivity of dendritic spines, for regulating glutamate receptor phosphorylation and for PKA-meditated enhancement of LTP induction.
Our results confirm previous studies of the distribution of PKA at the level of large neuronal compartments such as the soma, proximal dendrite and proximal axon (De Camilli et al., 1986) . However, the finding that PKA is excluded from dendritic spines is surprising. PKA is generally thought to be enriched in spines via synaptically localized AKAPs such as AKAP79/150 and Yotiao (Bauman et al., 2004; Carr et al., 1992; Lin et al., 1998; Tunquist et al., 2008; Westphal et al., 1999) . In contrast, we find that dendritic MAP2 is the dominant AKAP in pyramidal dendrites, restricting >97% of total RII subunits to dendritic shafts. These results are consistent with previous observations in MAP2 knockout mice showing that type II PKA subunits are largely lost in proximal hippocampal dendrites (Harada et al., 2002) . On the other hand, our results are at odds with a recent study suggesting that type II PKA is concentrated in dendritic spines in an AKAP150-dependent manner (Tunquist et al., 2008) . However, this study does not provide quantification of PKA subunit distributions and suffers from a lack of direct comparison with an evenly distributed cytosolic marker. RIIb has a very high affinity for the synaptically localized AKAP79/150 (Herberg et al., 2000) . Our results therefore imply that MAP2 is more abundant than all other AKAPs taken together.
Interactions between AKAPs and type II PKA have previously been shown to influence excitatory synaptic transmission (Rosenmund et al., 1994; Snyder et al., 2005) , but the underlying mechanism is not clear. Our results indicate that the interaction between MAP2 and type II PKA is an important regulator of postsynaptic function in synapses, possibly by enhancing LTP during behavioral salient conditions. Consistently, MAP2D1-158 mice have a profound deficit in contextual fear conditioning (Khuchua et al., 2003) . Furthermore, LTP is impaired even in heterozygous MAP2D1-158 mice (Figure 7) , in which PKA has only a slightly higher tendency to go into dendritic spines compared to widetype mice ( Figure 3C) . It therefore appears that regulating PKA access to spines is functionally extremely important. Finally, LTP triggered by tetanic stimuli is not impaired in these mice, confirming that PKA likely plays a regulatory rather than an obligatory role in synaptic plasticity (Iyengar, 1996) . Our study does not exclude important roles for other AKAPs in the postsynaptic density, such as AKAP79/150 (Bauman et al., 2004; Lu et al., 2007; Lu et al., 2008; Swayze et al., 2004; Tavalin et al., 2002; Tunquist et al., 2008) . Aspects of synaptic plasticity are impaired in mice lacking the PKA binding site of AKAP150 (Lu et al., 2007 (Lu et al., , 2008 . These synaptic AKAPs might recruit a low concentration of PKA into spines to phosphorylate specific targets, even though the major PKA reservoir resides in dendritic shafts. The precise functional differences of synaptic AKAPs and dendritic MAP2 remain to be identified.
PKA phosphorylation of S845 is important for the insertion of GluR1-containing AMPA receptors into synapses (Esteban et al., 2003; Lee et al., 2000; Man et al., 2007; Oh et al., 2006; Sun et al., 2005; Swayze et al., 2004) . We found that adrenergically induced GluR1 phosphorylation is abnormal in MAP2D1-158 mice, suggesting that the AMPA receptor is one of the substrates of MAP2-anchored PKA. How does PKA in dendritic shafts influence synaptic AMPA receptors and other synaptic substrates? We found that activated PKA catalytic subunits translocate from dendritic shafts to become enriched in dendritic spines. This phenomenon indicates that catalytic subunits bind to immobile partners in spines, which likely correspond to PKA substrates.
Although PKA is commonly thought to be localized close to its substrates via AKAPs, our finding suggests the inverse: AKAPs also play an important role in isolating the majority of PKA from its targets in the postsynaptic density until PKA is activated. Similar dynamics has been observed for calcium/calmodulin kinase II (CaMKII), which can also translocate from dendrites into spines in response to elevations of calcium (Gleason et al., 2003; Meyer and Shen, 2000; Shen and Meyer, 1999) . One beneficial consequence of such spatial regulation would be to minimize the effects of basal kinase activity on critical synaptic targets.
In contrast to type II PKA, we have found that type I PKA distributes rather evenly throughout the cell, in agreement with the thinking that type I PKA isoforms are mostly cytosolic (Francis and Corbin, 1994; Scott, 1991) . At dendrites, the endogenous PKA distribution mimics that of the type II PKA, suggesting that type II subunits are dominant over the type I subunits, consistent with the predominantly postsynaptic phenotypes in RIIb knockout mice (Inan et al., 2006) . On the other hand, the observation that type I PKA is relatively enriched in axons and presynaptic terminals compared to type II PKA, is consistent with a dominant role of type I PKA in axons (Brandon et al., 1997) .
Finally, we have found that PKA catalytic subunits rapidly move in and out of spines within seconds. PKA activity is therefore not expected to be spine-specific unless PKA is inactivated within several seconds. This is in agreement with the recent finding that synaptic plasticity at individual spines can influence the signaling of neighboring spines (Harvey and Svoboda, 2007) . Overall, our results provide a basis for understanding PKA signaling in neurons.
EXPERIMENTAL PROCEDURES
Molecular Biology cDNA constructs were made with standard subcloning methods. RIIa, RIa, RIb, and the catalytic subunit (type a) were from mouse and RIIb was from rat. A his-tag at the N terminus of RIa and RIb that came from the original cDNA was not removed. mEGFP (EGFP, A206K; Zacharias et al., 2002) was tethered to the end of the protein with a two-amino-acid-residue linker DI (EcoRV site) for all regulatory subunits. The end of the catalytic subunit was tethered to mEGFP (without M1 and V1a) with the linker IDYDVPDYASLM. Similar tagging did not interfere with PKA functions (Zaccolo and Pozzan, 2002) . DsRed Express was from Clontech and mCherry was derived from mRFP (Shaner et al., 2004) . cDNA constructs were subcloned into pCDNA3 or pRK5 for transient expression in cultured hippocampal slices and a custom vector for in utero electroporation (Gray et al., 2006) .
Transfection
Hippocampal neurons in cultured brain slices were transfected using biolistic gene transfer (Helios, Bio-Rad, 1.6 mm gold beads). Layer 2/3 neurons were transfected by in utero electroporation of E16 mouse embryos using a custom electroporator (Gray et al., 2006) . Dissociated neuronal cultured were transduced with lentiviral particles containing the GFP transgene.
Organotypic Slice Culture Cultured hippocampal slices were prepared (Stoppini et al., 1991) from P6-7 rats or mice in accordance with the animal care and use guidelines of Cold Spring Harbor Laboratory and Janelia Farm Research Institute. Experiments were performed at 8-16 days in vitro.
Acute Slice Preparation Coronal brain slices (300 mm thick) were prepared from mice with transfected Layer 2/3 neurons in accordance with institutional animal care and use guidelines. The cutting solution (gassed with 95% O 2 /5% CO 2 ) contained (in mM) 110 choline chloride, 25 NaHCO 3 , 25 D-glucose, 2.5 KCl, 7 MgCl 2 , 0.5 CaCl 2 , 1.25 NaH 2 PO 4 , 11.5 sodium ascorbate, and 3 sodium pyruvate. The slices were incubated in gassed artificial cerebral spinal fluid (ACSF) containing 127 NaCl, 25 NaHCO 3 , 25 D-glucose, 2.5 KCl, 1 MgCl 2 , 2 CaCl 2 , and 1.25 NaH 2 PO 4 at 35 C for 30 min and then at room temperature for up to 6 hr.
For LTP experiments, 400 mm thick coronal brain slices were sliced and recovered in gassed ACSF containing 1.3 MgCl 2 , 2.5 CaCl 2 .
Imaging For brain slice experiments we used a custom-built two-photon microscope controlled by ScanImage (Pologruto et al., 2003) . Two Ti:sapphire lasers (MaiTai, Spectra Physics) were combined with polarized optics and passed through the same set of scan mirrors and objective for simultaneous imaging and photoactivation/uncaging. Unless specified, a water-immersion objective from Olympus (603, 0.9 NA) was used. Experiments were performed at room temperature. Cultured hippocampal slices or acute brain slices were circularly perfused with gassed ACSF containing 4 mM Ca 2+ and 4 mM Mg
2+
. The imaging laser was tuned to 960 nm to simultaneously excite mEGFP and red fluorescent proteins (mCherry or DsRed Express). For experiments involving DsRed Express, a small amount of bleed-through into the green channel ($3%) was corrected in calculations (e.g., Figures 1B and 2B ). Both red proteins gave equivalent results, and all results were pooled together. The images from different color channels were individually adjusted for brightness and contrast before combined into a color image. Stocks of forskolin, IBMX, and norepinephrine (CalBiochem) were added to the circulating reservoir of ACSF where applicable. Imaging of layer 2/3 neurons in living mice was as described (Gray et al., 2006) .
Photoactivation
For these experiments the wavelength for imaging was 990 nm to excite PAGFP and mCherry while minimizing basal photoactivation. 810 nm was used for photoactivation. Time-lapse images were acquired every 0.256 s. The photoactivating illumination was applied at the eleventh frame within a small region of interest at a power empirically determined at the time of experiment. The location, timing, and intensity of the photoactivating stimulus were identical before and after the forskolin/IBMX treatment ( Figure 5 ). To average multiple trials, the integrated signal of PAGFP (green channel) within a region of interest was normalized by the red signal at the first frame before averaging, to minimize possible movement-related drift between trials. The resulting traces were fit with a single exponential, F = Ae Àðt=tÞ + B.
Electrophysiology and Glutamate Uncaging
Whole-cell voltage-clamp recording were performed using an Axopatch 200B amplifier (Axon). Electrophysiological signals were digitized at 10 kHz and acquired with custom software synchronized with ScanImage. The internal solution contained (in mM) 132 K-gluconate, 10 HEPES, 10 Na-phosphocreatine, 4 MgCl 2 , 4 Na 2 -ATP, 0.4 Na-GTP, 3 Na-ascorbate, and 0.02 Alexa 594, with osmolarity 295. Cells were held at À80 mV.
For LTP experiments we used 3-to 6-week-old mice. Field potentials were measured at room temperature in stratum radiatum ($100 mm from CA1 cell bodies) using a glass electrode (1-2 MU) filled with perfusion solution (ACSF containing 1.3 MgCl 2 , 2.5 CaCl 2 ). Synaptic responses (0.1-0.5 mV) were evoked with a monopolar glass electrode with single voltage pulse (200 ms, 20-40 V), placed 100 mm laterally from the recording electrode along the Schaffer collateral axons. Test stimuli were provided every 30 s. Two trains of 100 Hz stimuli with 30 s interval or 900 pulses of 10 Hz stimulation were used to trigger LTP as indicated. In some experiments 10 mM NE was applied from 15 to 5 min before LTP induction.
For glutamate uncaging, 2.5 mM MNI-caged-L-glutamate (Tocris) was added to the ACSF, together with 5 mM R-CPP and 1 mM TTX. To achieve photolysis the laser beam was parked at the tip of the spine head in the direction away from the parent dendrite. Test pulses (1 ms duration) were delivered at 0.1 Hz. The power was 60 mW in the objective back focal plane, of which approximately 18% was transmitted through the objective. Only spines that were well separated from both the dendrite and neighboring spines were selected for analysis. The uncaging depth in the slice was restricted to 10-40 mm. uEPSCs amplitudes were measured, based on averages of four trials, as the difference between the mean current amplitude over a 2 ms window around the peak and the mean current amplitude over a 100 ms window before the stimulus.
Data Analysis
Measurements were performed using custom software written in Matlab. For spine enrichment index (SEI) measurements, regions of interest (ROIs) were drawn manually on the x-y max projection of a spine and its parent dendrite. The green (G) and red (R) signals within the ROIs were then averaged after background subtraction (from a manually selected background ROI) for three consecutive z slices (1 mm z steps) with the middle z slice giving the highest integrated value in red among all z slices. SEI is defined as log 2 ([G/R] spine / [G/R] dendrite ).
The fraction of PKA in dendritic shafts was calculated based on a recent study using electron microscopy (Zito et al., 2009) . Two segments of thin dendrites (diameter being 1.0 and 1.1 mm respectively; and length being 65 and 44 mm, respectively) contain 18 and 22 spines respectively. The averaged volume of the spines was measured to be 0.13fL. The relative spine volume compared to the total volume (spine and dendrite) is calculated to be V spine = 6%. The fraction of PKA in dendritic shafts was calculated as (1 À V spine )/ [2 SEI V spine + (1 À V spine )].
For Figure 1C , the soma center was determined as follows: an ROI was drawn around the soma. The soma was segmented by thresholding (background + 33 SD). The center was the point transected by three orthogonal planes which divide the soma in half. The ratios of average green over average red were calculated from background subtracted pixels that were binned every 5 mm along the radius away from the center.
Averaged data are presented as mean ± SEM unless noted otherwise. n indicates the number of experiments. p values are from t tests, unless noted otherwise.
Dissociated Neuronal Culture and Immunostaining Imaging Dissociated hippocampal neurons from E18 rat pups were plated onto polylysine coated coverslips in Neurobasal-A medium (Invitrogen) supplemented with 2% B27, 1 mM Glutamax, and 5% equine serum (Hyclone). Fifty micromolar FDUR was added after 5 days. Every 3-4 days, half of the medium was removed and replaced with fresh plating medium with equine serum omitted. At DIV 14, cultures were transduced with lentiviral particles containing the GFP transgene.
At DIV 28, cultures were fixed in 4% paraformaldehyde, 4% sucrose in PBS for 30 min at room temperature, then permeabilized with 0.2% Triton X-100 in PBS on ice for 10 min. The coverslips were then blocked with 10% normal goat serum in PBS for 1 hr followed by incubation with primary antibodies (mouse anti-GFP, 1:1000, Chemicon MAB3580, rabbit anti GFP, homemade, rabbit anti-PKA catalytic subunit [PKA-NT], 10 mg/ml, USA Biologicals #P9102-91A, mouse monoclonal anti-PKA catalytic subunit, 10 mg/ml, BD #610980, and mouse monoclonal anti-PKA RIIb, 10 mg/ml, BD #610625) diluted in blocking buffer for 2 hr and then secondary antibodies (Alexa-488-and -594-conjugated goat anti-mouse and rabbit antibodies respectively, Molecular Probes) for 1 hr at room temperature. Coverslips were mounted in Permafluor (Thermo Electron) and imaged using a confocal microscope (Zeiss, 633, 1.4 NA).
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